FORM 8.3 - UDG HEALTHCARE PLC- AMENDMENT

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	UDG HEALTHCARE PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	28 July 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		6,753,954	2.68%	197,731	0.08%
(2)	Derivatives (other than options):
		141,935	0.06%	6,498,528	2.58%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
(4)	TOTAL:
		6,895,889	2.74%	6,696,259	2.66%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	43	10.7700 GBP
Purchase	273	10.7850 GBP
Purchase	20,406	10.8000 GBP
Purchase	117,187	10.7800 GBP
Sale	5	10.7888 GBP
Sale	43	10.7700 GBP
Sale	833	10.7791 GBP
Sale	5,911	10.7800 GBP
Sale	9,463	10.7805 GBP
Sale	21,775	10.7817 GBP
Sale	37,765	10.7908 GBP

(b) Derivatives transactions (other than options transactions)

Product Name	Nature of transaction	Number of relevant securities	Price per
			unit
CFD	Long	833	10.7791 GBP
SWAP	Long	6,566	10.7791 GBP
SWAP	Long	15,473	10.7800 GBP
SWAP	Short	432	10.7900 GBP
CFD	Short	1,198	10.7814 GBP
SWAP	Short	2,210	10.7828 GBP
SWAP	Short	46,017	10.7800 GBP
CFD	Short	58,137	10.7808 GBP

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	30 Jul 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection